Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Genes, Chromosomes & Cancer|November 14, 2006
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1Ella Bowles, Timothy W Corson, Jane Bayani, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 29, 2018
A Comparison of Pathologic Outcomes of Open, Laparoscopic, and Robotic Resections for Rectal Cancer Using the ACS-NSQIP Proctectomy-Targeted Database: a Propensity Score AnalysisRichard Garfinkle, Maria Abou-Khalil, Sahir Bhatnagar, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transitionKit-Ying Chung, Ibis K-C Cheng, Arthur K-K Ching, et al.
International Journal of Oncology|June 7, 2003
Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cellsAlfred S L Cheng, Henry L Y Chan, Wai K Leung, et al.
Theranostics|August 15, 2019
APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable targetHuarong Chen, Chi-Chun Wong, Dabin Liu, et al.
Cancer Research|August 15, 2008
Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrestJennifer W-M Gho, Wai-Ki Ip, Kathy Y-Y Chan, et al.
JHEP Reports : Innovation in Hepatology|November 24, 2025
Non-canonical splice variant of PFKFB4 in hepatocellular carcinoma activates AKT through direct interactionHo-Lee Wan, Wenjie Luo, Ho Ting Henry Chan, et al.
International Journal of Cancer|March 4, 2014
Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinomaKeng Po Lai, Jiawei Chen, Mian He, et al.
Pageof 13